FDA Cybersecurity: New Hurdles for AI Medical Device Investors
The field of AI-driven medical devices is undergoing a seismic shift, with the FDA asserting unprecedented authority over cybersecurity. This isn’t merely an advisory update.…
The field of AI-driven medical devices is undergoing a seismic shift, with the FDA asserting unprecedented authority over cybersecurity. This isn’t merely an advisory update.…
The promise of AI in healthcare is immense, yet its clinical integration hinges on more than just algorithmic prowess. For AI-driven Software as a Medical…
The promise of artificial intelligence in cardiovascular health is undeniable, offering unprecedented capabilities for early detection, personalized treatment, and improved patient outcomes. However, the path…
The medical device world is changing, especially for anyone building AI health tools. The FDA’s new Quality System Regulation Amendment (QMSR) is a huge part…
The FDA had issued a final rule to regulate Laboratory Developed Tests (LDTs) that was intended to fundamentally redefine the oversight field for diagnostic technologies.…
The promise of adaptive machine learning (ML) in Software as a Medical Device (SaMD) is deep: algorithms that continually learn and improve postmarket, enhancing diagnostic…
New AI-powered health tools are offering incredible new ways to diagnose and treat patients. But for the developers building them, the global market is a…
Digital health regulation is changing, but not through the slow grind of formal rulemaking you’re used to. The FDA knows it can’t keep up with…
Artificial intelligence is evolving so quickly in healthcare that it’s creating both massive opportunities and a regulatory mess. The old way of getting a medical…
The way the FDA regulates AI health tools is finally catching up to reality. We’re shifting from a reactive, one-and-done clearance model to a system…